Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery P. Forget, C. Bentin, J.-P. Machiels, M. Berliere, P.G. Coulie, M. De Kock British Journal of Anaesthesia Volume 113, Pages i82-i87 (July 2014) DOI: 10.1093/bja/aet464 Copyright © 2014 The Author(s) Terms and Conditions
Fig 1 Study flow chart. British Journal of Anaesthesia 2014 113, i82-i87DOI: (10.1093/bja/aet464) Copyright © 2014 The Author(s) Terms and Conditions
Fig 2 Kaplan–Meier curves of DFS for 720 patients receiving or not an intraoperative administration of NSAIDs (ketorolac or diclofenac) during conservative breast cancer surgery. Univariate analysis by log-rank test. British Journal of Anaesthesia 2014 113, i82-i87DOI: (10.1093/bja/aet464) Copyright © 2014 The Author(s) Terms and Conditions
Fig 3 Kaplan–Meier curves of OS for 720 patients receiving or not an intraoperative administration of NSAIDs (ketorolac or diclofenac) during conservative breast cancer surgery. Univariate analysis by log-rank test. British Journal of Anaesthesia 2014 113, i82-i87DOI: (10.1093/bja/aet464) Copyright © 2014 The Author(s) Terms and Conditions
Fig 4 Kaplan–Meier curves of DFS for 451 patients with an NLR >3.3, or not, before conservative breast cancer surgery. Univariate analysis by log-rank test. British Journal of Anaesthesia 2014 113, i82-i87DOI: (10.1093/bja/aet464) Copyright © 2014 The Author(s) Terms and Conditions
Fig 5 Kaplan–Meier curves of OS for 451 patients with an NLR >3.3, or not, before conservative breast cancer surgery. Univariate analysis by log-rank test. British Journal of Anaesthesia 2014 113, i82-i87DOI: (10.1093/bja/aet464) Copyright © 2014 The Author(s) Terms and Conditions